{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:47:13Z","timestamp":1648972033157},"reference-count":31,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.3892\/mmr.2016.5684","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T20:41:31Z","timestamp":1503520891000},"page":"3791-3797","source":"Crossref","is-referenced-by-count":1,"title":["Low mutation percentage of KRAS and BRAF genes in Brazilian anal tumors"],"prefix":"10.3892","volume":"14","author":[{"given":"Lucas Tadeu","family":"Bidinotto","sequence":"first","affiliation":[]},{"given":"Carlos A R","family":"V\u00e9o","sequence":"additional","affiliation":[]},{"given":"Edgar Aleman","family":"Loaiza","sequence":"additional","affiliation":[]},{"given":"Alessandra Paulino Santos","family":"De Fran\u00e7a","sequence":"additional","affiliation":[]},{"given":"Adriana Tarla","family":"Lorenzi","sequence":"additional","affiliation":[]},{"given":"Luciana Albina Reis","family":"Rosa","sequence":"additional","affiliation":[]},{"given":"Cristina Mendes","family":"De Oliveira","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 Eduardo","family":"Levi","sequence":"additional","affiliation":[]},{"given":"Cristovam","family":"Scapulatempo-Neto","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"given":"Rui Manuel","family":"Reis","sequence":"additional","affiliation":[]}],"member":"2249","published-online":{"date-parts":[[2016,8,26]]},"reference":[{"key":"key20180108025823_b1-mmr-14-04-3791","volume-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","year":"2010"},{"key":"key20180108025823_b2-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.bjc.6605984","article-title":"Prognostic biomarkers in squamous cell carcinoma of the anus: A systematic review","volume":"103","author":"Lampejo","year":"2010","journal-title":"Br J Cancer"},{"key":"key20180108025823_b3-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.suronc.2005.07.002","article-title":"Squamous cell carcinoma of the anal canal","volume":"14","author":"Rousseau","year":"2005","journal-title":"Surg Oncol"},{"key":"key20180108025823_b4-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20180108025823_b5-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1055\/s-0031-1272824","article-title":"Neoplasms of anal canal and perianal skin","volume":"24","author":"Leonard","year":"2011","journal-title":"Clin Colon Rectal Surg"},{"key":"key20180108025823_b6-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/bjs.1800810405","article-title":"Malignant anal tumours","volume":"81","author":"Deans","year":"1994","journal-title":"Br J Surg"},{"key":"key20180108025823_b7-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clcc.2015.07.007","article-title":"Comparative survival of patients with anal adenocarcinoma, squamous cell carcinoma of the anus, and rectal adenocarcinoma","volume":"15","author":"Franklin","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"key20180108025823_b8-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/COH.0b013e32831b9c81","article-title":"Human papillomavirus vaccines and anal carcinoma","volume":"4","author":"Franceschi","year":"2009","journal-title":"Curr Opin HIV AIDS"},{"key":"key20180108025823_b9-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2013.52.3464","article-title":"Human papillo-mavirus genotyping and p16 expression as prognostic factors for patients with American joint committee on cancer stages I to III carcinoma of the anal canal","volume":"32","author":"Serup-Hansen","year":"2014","journal-title":"J Clin Oncol"},{"key":"key20180108025823_b10-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","article-title":"Molecular biology of human papillomavirus infection and cervical cancer","volume":"110","author":"Doorbar","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"key20180108025823_b11-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1007\/s13277-015-3205-9","article-title":"Clinical characteristics of women diagnosed with carcinoma who tested positive for cervical and anal high-risk human papillomavirus DNA and E6 RNA","volume":"36","author":"Veo","year":"2015","journal-title":"Tumour Biol"},{"key":"key20180108025823_b12-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2015.08.004","article-title":"Prognostic relevance of HPV infection and p16 overexpression in squamous cell anal cancer","volume":"93","author":"Mai","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20180108025823_b13-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/bjc.2015.20","article-title":"HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53","volume":"112","author":"Meulendijks","year":"2015","journal-title":"Br J Cancer"},{"key":"key20180108025823_b14-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"43594","DOI":"10.18632\/oncotarget.6202","article-title":"Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas","volume":"6","author":"Smaglo","year":"2015","journal-title":"Oncotarget"},{"key":"key20180108025823_b15-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the effcacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20180108025823_b16-mmr-14-04-3791","article-title":"Characterization of topoisomerase II alpha (TOP2A) and minichromosome maintenance protein (MCM)2 expression in anal carcinoma","author":"Scapulatempo-Neto","year":"2016","journal-title":"Oncol Lett"},{"key":"key20180108025823_b17-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3892\/or.2014.3338","article-title":"KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy","volume":"32","author":"Yamane","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180108025823_b18-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1148\/rg.2015150037","article-title":"Anorectal cancer: Critical anatomic and staging distinctions that affect use of radiation therapy","volume":"35","author":"Matalon","year":"2015","journal-title":"Radiographics"},{"key":"key20180108025823_b19-mmr-14-04-3791","first-page":"5171","article-title":"KRAS mutation testing in metastatic colorectal cancer","volume":"18","author":"Ta n","year":"2012","journal-title":"World J Gastroenterol"},{"key":"key20180108025823_b20-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-230X-14-73","article-title":"KRAS mutations: Variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients","volume":"14","author":"Gil Ferreira","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"key20180108025823_b21-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1158\/1078-0432.CCR-13-2365","article-title":"Molecular pathways: The basis for rational combination using MEK inhibitors in KRAS-mutant cancers","volume":"20","author":"Okumura","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20180108025823_b22-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.radonc.2013.08.002","article-title":"p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: Correlation with outcomes following chemo-radiotherapy","volume":"109","author":"Gilbert","year":"2013","journal-title":"Radiother Oncol"},{"key":"key20180108025823_b23-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/bjc.2012.479","article-title":"EGFR and K-ras gene mutation status in squamous cell anal carcinoma: A role for concurrent radiation and EGFR inhibitors?","volume":"107","author":"Paliga","year":"2012","journal-title":"Br J Cancer"},{"key":"key20180108025823_b24-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"e92071","DOI":"10.1371\/journal.pone.0092071","article-title":"KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC)","volume":"9","author":"Casadei Gardini","year":"2014","journal-title":"PLoS One"},{"key":"key20180108025823_b25-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.humpath.2014.08.001","article-title":"No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16 (INK4a) status","volume":"45","author":"Prigge","year":"2014","journal-title":"Hum Pathol"},{"key":"key20180108025823_b26-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/apm.12306","article-title":"KRAS and BRAF mutations in anal carcinoma","volume":"123","author":"Serup-Hansen","year":"2015","journal-title":"APMIS"},{"key":"key20180108025823_b27-mmr-14-04-3791","first-page":"513","article-title":"EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer","volume":"29","author":"Martin","year":"2014","journal-title":"Histol Histopathol"},{"key":"key20180108025823_b28-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"key20180108025823_b29-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1080\/15384047.2015.1113356","article-title":"Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites","volume":"16","author":"El-Deiry","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"key20180108025823_b30-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","article-title":"Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative groups","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"key20180108025823_b31-mmr-14-04-3791","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000259615","article-title":"Cetuximab-based treatment of metastatic anal cancer: Correlation of response with KRAS mutational status","volume":"77","author":"Lukan","year":"2009","journal-title":"Oncology"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T00:16:34Z","timestamp":1515370594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2016.5684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,26]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,8,26]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.3892\/mmr.2016.5684"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2016.5684","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,26]]}}}